Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 1 drug for further processing, 1 vaccine. By marketing category: BLA 1, DRUG FOR FURTHER PROCESSING 1.
| Dosage form | NDCs |
|---|---|
| spray | 2 |
| Route | NDCs |
|---|---|
| nasal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| medimmune, llc | 1 |
| medimmune, u.k. limited | 1 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| FluMist | Influenza Vaccine Live Intranasal | spray, nasal | 66019-113BLA |
| - | Influenza Vaccine Live Intranasal | spray | 66020-051DRUG FOR FURTHER PROCESSING |
Enquiry
Common questions
- Is MedImmune, U.K. Limited FDA approved?
- MedImmune, U.K. Limited holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does MedImmune, U.K. Limited make?
- 2 products are listed under MedImmune, U.K. Limited in the openFDA NDC Directory, most often as spray. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.